Frederick Witten
Urology · Jeffersonville, INNPI 1588657654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Medtronic at 51.5% of the total. Reporting peaked in 2022 at $771 and has fallen 94.0% since, to $46 in 2023. That places this record below the midpoint for urology clinicians in IN, where the typical reported total is $3,350.
Across 85 payments — averaging $33.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Astellas Pharma US Inc$369
- Urogen Pharma, Inc.$138
- Endo Pharmaceuticals Inc.$116
- Teleflex LLC$94
- Blue Earth Diagnostics$87
- plus $574 from 21 others
Across 2 payments — averaging $1184.27 each. An ownership or investment interest held by the physician or an immediate family member.
- Louisville URS Solutions, LLC$2K
What the payments were for
- Food & beverage$2,837100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 20 | $1,460 |
| Astellas Pharma US Inc | 15 | $369 |
| Urogen Pharma, Inc. | 2 | $138 |
| Endo Pharmaceuticals Inc. | 6 | $116 |
| Teleflex LLC | 1 | $94 |
| Blue Earth Diagnostics | 4 | $87 |
| Johnson & Johnson | 5 | $61 |
| Antares Pharma, Inc. | 4 | $58 |
| Myovant Sciences Inc. | 3 | $49 |
| AbbVie | 3 | $46 |
| Procept Biorobotics Corporation | 1 | $44 |
| Clarus Therapeutics Inc. | 3 | $41 |
| Novartis | 3 | $37 |
| Accord Healthcare, Inc. | 2 | $33 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| Urovant Sciences Inc | 1 | $17 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Axonics, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Bayer | 1 | $15 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
| Pfizer | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,837 in reported general payments places this provider in the 45th percentile of 272 urology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 34 | $28,069 |
| Potassium Citrate ErPotassium Citrate | 23 | $3,257 |
| Tamsulosin Hcl | 188 | $2,973 |
| Finasteride | 173 | $2,179 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $1,075 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 27 | $649 |
| Doxazosin Mesylate | 15 | $256 |
| Dutasteride | 14 | $189 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $174 |
| Hydrochlorothiazide | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $369 | $28,06934 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 272 urology providers in Indiana.
Other urology in Jeffersonville
- James BailenJeffersonville$143K
- Greg SteinbockJeffersonville$134K
- Ryan MaloneJeffersonville$97K
- William SchmiedJeffersonville$58K
- Barry PechaJeffersonville$50K
- David RosenbaumJeffersonville$39K
- John EiflerJeffersonville$26K
- Ganesh RaoJeffersonville$19K
- Bradley BellJeffersonville$16K
- Aaron BeckerJeffersonville$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.